Paulo Carvalho

Paulo Carvalho

Plus aucun poste en cours

Health Technology
Consumer Services

Provenance du réseau au premier degré de Paulo Carvalho

EntitéType d'entitéIndustrie
Public Company Biotechnology 15

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Paulo Carvalho via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
GILEAD SCIENCES, INC. Biotechnology

Langdon L. Miller

Corporate Officer/Principal

VERTEX PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Mark de Rosch

Corporate Officer/Principal

Medical Specialties

Mark Plavsic

Corporate Officer/Principal

PTC THERAPEUTICS, INC. Pharmaceuticals: Major

Langdon L. Miller

Chief Tech/Sci/R&D Officer

COLLEGIUM PHARMACEUTICAL, INC. Pharmaceuticals: Major

Alex Dasalla

Public Communications Contact

CHIASMA, INC. Pharmaceuticals: Major

Joseph Lyons

Human Resources Officer

Pharmaceuticals: Major

Antony Mattessich

Chief Executive Officer

Pharmaceuticals: Major

Langdon L. Miller

Chief Tech/Sci/R&D Officer

OCULAR THERAPEUTIX, INC. Pharmaceuticals: Major

Antony Mattessich

Chief Executive Officer

Investment Managers

Karan Takhar

Portfolio Manager-Equities

Data Processing Services

Karan Takhar

Director/Board Member

Pharmaceuticals: Major

Karan Takhar

Director/Board Member

NOVARTIS AG Pharmaceuticals: Major

Antony Mattessich

Janet Hopkins

Corporate Officer/Principal

Corporate Officer/Principal

Medical Specialties

Mark de Rosch

Corporate Officer/Principal

Massachusetts Institute of Technology College/University

Karan Takhar

Undergraduate Degree

College/University

Langdon L. Miller

Doctorate Degree

McMaster University College/University

Janet Hopkins

Doctorate Degree

University of California San Diego College/University

Mark de Rosch

Doctorate Degree

Cambridge College College/University

Joseph Lyons

Graduate Degree

Investment Trusts/Mutual Funds

Langdon L. Miller

Corporate Officer/Principal

Property/Casualty Insurance

Langdon L. Miller

Director/Board Member

AKEBIA THERAPEUTICS, INC. Pharmaceuticals: Major

Mark de Rosch

General Counsel

FATE THERAPEUTICS, INC. Biotechnology

Mark Plavsic

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Generic

Mark de Rosch

Corporate Officer/Principal

EPIZYME, INC. Biotechnology

Mark de Rosch

General Counsel

KARYOPHARM THERAPEUTICS INC. Pharmaceuticals: Major

Chris Primiano

General Counsel

Pharmaceuticals: Major

Antony Mattessich

Chief Executive Officer

Berlex Laboratories, Inc.

Mark de Rosch

General Counsel

University of Wisconsin Parkside College/University

Mark de Rosch

Undergraduate Degree

Miscellaneous Commercial Services

Mark de Rosch

Corporate Officer/Principal

Biotechnology

Mark Plavsic

Corporate Officer/Principal

Chemicals: Specialty

Mark Plavsic

Director/Board Member

NIGHTSTAR THERAPEUTICS PLC Pharmaceuticals: Major

Mark de Rosch

General Counsel

Miscellaneous Commercial Services

Karan Takhar

David Johnson

Director/Board Member

Director/Board Member

Biotechnology

Joël Jean-Mairet

Director/Board Member

LAVA THERAPEUTICS N.V. Biotechnology

Joël Jean-Mairet

Director/Board Member

Biotechnology

Joël Jean-Mairet

Director/Board Member

Biotechnology

Janet Hopkins

Chief Executive Officer

Dunn Gardens

Langdon L. Miller

Director/Board Member

Biotechnology

Karan Takhar

Director/Board Member

ONCTERNAL THERAPEUTICS, INC. Pharmaceuticals: Major

Langdon L. Miller

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Karan Takhar

Director/Board Member

ZENTALIS PHARMACEUTICALS, INC. Biotechnology

Karan Takhar

David Johnson

Director/Board Member

Chairman

GYROSCOPE THERAPEUTICS HOLDINGS PLC Biotechnology

Janet Hopkins

Director/Board Member

Investment Managers

Karan Takhar

Private Equity Investor

Statistiques

Internationale

Etats-Unis 38
Royaume-Uni 6
Canada 3
Espagne 3
Suisse 2

Sectorielle

Health Technology 33
Consumer Services 6
Finance 5
Commercial Services 5
Technology Services 2

Opérationnelle

Director/Board Member 86
Corporate Officer/Principal 18
Independent Dir/Board Member 17
Chief Executive Officer 12
Chief Tech/Sci/R&D Officer 12
  1. Bourse
  2. Insiders
  3. Paulo Carvalho
  4. Connexions Sociétés
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT